Link William J PhD's Form 4 filing
Tarsus Pharmaceuticals, Inc. (TARS) · filed Dec 17, 2025
- Accession no.
- 0001228684-25-000005
- Filed
- Dec 17, 2025
- Trade date
- Dec 15, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.86M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Link William J PhDCIK 0001228684 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Common Stock | SSaleDisposed | −5,046 | $80.80 | −$407,716.8 | 136,286 | Direct | |
| Dec 15, 2025 | Common Stock | SSaleDisposed | −6,306 | $81.75 | −$515,515.5 | 129,980 | Direct | |
| Dec 15, 2025 | Common Stock | SSaleDisposed | −1,148 | $82.39 | −$94,583.72 | 128,832 | Direct | |
| Dec 15, 2025 | Common Stock | SSaleDisposed | −5,680 | $80.71 | −$458,432.8 | 4,766 | Indirect | |
| Dec 15, 2025 | Common Stock | SSaleDisposed | −4,766 | $81.50 | −$388,429 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.